What is the appropriate evaluation and management for vulvar swelling?

Evaluation and Management of Vulvar Swelling

Begin by determining whether the swelling is acute or chronic, unilateral or bilateral, and whether it is associated with pain, discharge, trauma, or systemic symptoms—this distinction immediately narrows the differential and guides initial management.

Initial Clinical Assessment

Key History Elements

• Onset and duration: Acute swelling (<72 hours) suggests trauma, infection, or allergic reaction; chronic swelling points toward lymphatic obstruction, inflammatory conditions, or neoplasm 1
• Associated symptoms: Pruritus with white discharge suggests candidiasis 2; malodorous yellow-green discharge indicates trichomoniasis 3; burning post-coitus may indicate seminal plasma hypersensitivity or contact dermatitis 3
• Trauma history: Recent sexual intercourse, particularly vigorous, raises concern for vulvar hematoma 4, 5; recent laparoscopy can cause unilateral vulvar edema through fluid tracking 6
• Pregnancy status: Vulvar edema is common in pregnancy and requires conservative management 1

Physical Examination Findings

• Unilateral labial swelling with ecchymosis: Suspect vulvar hematoma, especially if post-coital or post-trauma 4, 5
• Bilateral swelling with erythema and white discharge: Likely vulvovaginal candidiasis 2
• Fluctuant mass: Consider Bartholin gland cyst or abscess 1
• Fixed, indurated, or ulcerated lesions: Mandate biopsy to exclude vulvar malignancy 2

Diagnostic Workup

Infectious Causes

• Measure vaginal pH immediately: pH <4.5 strongly suggests candidiasis; pH >4.5 indicates bacterial vaginosis or trichomoniasis 3
• Perform wet-mount microscopy with 10% KOH: Identifies yeast/pseudohyphae (candidiasis), motile trichomonads (trichomoniasis), or clue cells (bacterial vaginosis) 2, 3
• Obtain vaginal cultures when microscopy is negative but symptoms persist: Microscopy has only 58% sensitivity for Candida 3
• Use nucleic acid amplification testing (NAAT) for superior diagnostic performance: Achieves ~90% sensitivity and 94% specificity for Candida 3

Traumatic Causes

• Order pelvic CT if vulvar hematoma is suspected and examination is equivocal: Distinguishes blood from abscess or deep venous thrombosis 4
• Perform serial examinations every 4-6 hours for expanding hematomas: Most resolve spontaneously, but surgical evacuation is required if expanding or >10 cm 4, 5

Neoplastic Evaluation

• Biopsy any persistent, fixed, ulcerated, or hyperkeratotic lesion: Vulvar squamous cell carcinoma accounts for 90% of vulvar malignancies and requires tissue diagnosis 2
• Consider imaging (pelvic MRI or CT) for lesions >2 cm or with palpable inguinal lymphadenopathy: Staging determines surgical approach 2

Management by Etiology

Vulvovaginal Candidiasis

• Treat uncomplicated cases with single-dose oral fluconazole 150 mg OR short-course topical azole (1-3 days): Achieves 80-90% cure rate 2, 3
• Topical options include: Miconazole 2% cream 5g intravaginally for 7 days; clotrimazole 1% cream 5g for 7-14 days; terconazole 0.8% cream 5g for 3 days; or tioconazole 6.5% ointment 5g as single application 2, 3
• For recurrent vulvovaginal candidiasis (≥4 episodes/year): Obtain cultures to confirm species and exclude fluconazole-resistant Candida glabrata (present in 10-20% of recurrent cases) before initiating maintenance therapy 2, 3
• Extended initial therapy (7-14 days topical azole or fluconazole 150 mg repeated 3 days later) followed by 6-month maintenance regimen: Use clotrimazole 500mg vaginal suppository weekly, ketoconazole 100mg daily, fluconazole 100-150mg weekly, or itraconazole 400mg monthly 2

Trichomoniasis

• Treat with metronidazole 500 mg orally twice daily for 7 days: Single-dose regimens are ineffective 3
• Treat sexual partners simultaneously: Prevents reinfection 3

Seminal Plasma Hypersensitivity

• Recommend consistent condom use: Effectively prevents allergic reactions 3
• Prescribe epinephrine auto-injector: For possible systemic reactions 3
• Confirm diagnosis by demonstrating symptom prevention with condom use and consider skin-prick testing with partner's seminal plasma: After screening for viral hepatitis, syphilis, and HIV 3

Vulvar Hematoma

• Manage conservatively with ice packs, compression, bed rest, and analgesia for stable hematomas <10 cm: Most resolve spontaneously within 7-10 days 5
• Perform surgical evacuation for expanding hematomas, those >10 cm, or causing urinary retention: Approximately 150cc of clot is typically evacuated 4
• Maintain serial examinations to distinguish uncomplicated from surgical cases: 5

Lichen Sclerosus

• Initiate ultra-potent topical corticosteroid (clobetasol propionate 0.05%) applied once daily for 3 months: Then taper to maintenance dosing 2
• Schedule follow-up at 3 months and 6 months: Assess response, ensure proper application technique, and screen for complications including scarring and malignancy 2
• Provide written self-monitoring instructions: Any change in symptoms, lack of response, new erosions, ulceration, or lumps requires urgent specialist referral 2

Suspected Malignancy

• Perform wide local excision or radical local resection with ipsilateral or bilateral inguinofemoral lymph node evaluation: Depends on depth of invasion and lesion location 2
• For lesions with ≤1 mm invasion: Wide local excision with observation is sufficient 2
• For lesions with >1 mm invasion: Radical local resection or modified radical vulvectomy with sentinel lymph node biopsy or complete lymphadenectomy is required 2

Common Pitfalls and Caveats

• Do not rely solely on wet-mount microscopy for Candida diagnosis: Limited 58% sensitivity leads to false-negatives; obtain cultures or NAAT when clinical suspicion is high 3
• Do not prescribe over-the-counter antifungals without confirmed diagnosis: Delays appropriate treatment of alternative etiologies 3
• Do not attribute recurrent symptoms to treatment failure without reconsidering alternative diagnoses: Including desquamative inflammatory vaginitis, lichen sclerosus, or vulvodynia 3
• Do not start empiric fluconazole maintenance without species confirmation: C. glabrata is intrinsically fluconazole-resistant 2, 3
• Do not delay surgical consultation for expanding vulvar hematomas: Testicular/ovarian viability may be compromised 4
• Do not dismiss persistent, fixed, or ulcerated lesions: Biopsy is mandatory to exclude vulvar malignancy 2

Follow-Up Recommendations

• Schedule follow-up only if symptoms persist or recur within 2 months of initial therapy: 3
• For persistent symptoms despite appropriate treatment: Obtain repeat cultures, reassess vaginal pH, and consider alternative diagnoses 3
• For vulvar hematomas managed conservatively: Serial examinations every 4-6 hours until stable, then daily until resolution 5
• For lichen sclerosus: Follow-up at 3 months and 6 months, then annually if well-controlled 2